CAS: 41826-92-0; 4-Oxo-4-(2,4,5-Triethoxyphenyl)Butanoic Acid

上下游产品

methyl hydrogen succinate 1,2,4-triethoxy-benzene4-[4-oxo-4-(2,4,5-triethoxy-phenyl)-butyryl]-morpholine 3-(2'-hydroxy-4',5'-diethoxybenzoyl)propionic acid 4-(2,4,5-Triethoxybenzoyl)-buttersaeure

1,2,4-三乙氧基苯 以45%的收率获得产物
参考文献:Murata Tadakazu; Satoh Hiroshi; Nohara Akira; Ukawa Kiyoshi; Sugihara Hir+,Eur. J. Med. Chem.,1977,12,No 1,17-20
标题:Murata Tadakazu; Satoh Hiroshi; Nohara Akira; Ukawa Kiyoshi; Sugihara Hir+,Eur. J. Med. Chem.,1977,12,No 1,17-20

专利信息

专利号:US-7993390-B2
优先权日:2002-02-08
标 题:Implantable or insertable medical device resistant to microbial growth and biofilm formation
发明人：MILLER KATHLEEN M; BUCAY-COUTO WEENNA; LI JIANMIN
权利人:BOSTON SCIENT SCIMED INC
摘要:Disclosed are implantable or insertable medical devices that provide resistance to microbial growth on and in the environment of the device and resistance to microbial adhesion and biofilm formation on the device. In particular, the invention discloses implantable or insertable medical devices that comprise at least one biocompatible matrix polymer region, an antimicrobial agent for providing resistance to microbial growth and/or a microbial adhesion/biofilm synthesis inhibitor for inhibiting the attachment of microbes and the synthesis and accumulation of biofilm on the surface of the medical device. Also disclosed are methods of manufacturing such devices under conditions that substantially prevent preferential partitioning of any of said bioactive agents to a surface of the biocompatible matrix polymer and substantially prevent chemical modification of said bioactive agents.